Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting

Core Insights - Bionano Genomics, Inc. is participating in the ACMG Annual Clinical Genetics Meeting 2025, showcasing its optical genome mapping (OGM) technology in various research areas [2][4] - The conference will feature presentations on OGM's applications in hematological malignancies, constitutional genetic disorders, and rare genetic diseases [2][4] - The event highlights the growing impact of OGM in clinical research and its acceptance for routine use in cytogenetics [5][4] Company Overview - Bionano Genomics provides genome analysis solutions aimed at transforming the understanding of the genome through OGM technology [6] - The company offers diagnostic services, software, and OGM solutions applicable across basic, translational, and clinical research [6] - Bionano's mission includes enabling researchers and clinicians to address challenging biological and medical questions [6] Conference Details - The ACMG Annual Meeting will take place from March 18-22, 2025, in Los Angeles, USA, gathering industry professionals and researchers [3] - Key presentations include topics such as the evolution of cytogenomic technology and the integration of OGM with targeted next-generation sequencing (NGS) [4][5] - Notable speakers include Dr. Adam Smith, Dr. Laila El-Khattabi, and Dr. Nikhil Sahajpal, who will present findings from various clinical research cohorts [4][5] Research Focus - OGM is being utilized to improve the diagnosis of structural variations and aneuploidies in constitutional and reproductive disorders [4] - The CHROMAPS project, a multi-institutional collaboration, aims to evaluate structural variations in genetic disorders using OGM [4] - Presentations will also cover OGM's role in advancing precision therapeutics and CAR-T cell-based immunotherapies [5]